EMICIZUMAB

Search structure
Trade Names:
Synonyms:
Status: Approved (2017)
Entry Type: Antibody
Molecule Category: UNKNOWN
ATC: B02BX06
UNII: 7NL2E3F6K3

Pharmacology

Action Mechanism of Action Reference
OTHER Coagulation factor IX and X other PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hemophilia A 4 D006467 FDA

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
18.92
Vascular disorders
18.92
General disorders and administration site conditions
13.51
Musculoskeletal and connective tissue disorders
13.51
Infections and infestations
4.89
Nervous system disorders
4.89
Investigations
4.05
Skin and subcutaneous tissue disorders
3.74
Respiratory, thoracic and mediastinal disorders
3.43
Gastrointestinal disorders
3.01
Cardiac disorders
2.6

Cross References

Resources Reference
CAS NUMBER 1610943-06-0
ChEMBL CHEMBL3833393
FDA SRS 7NL2E3F6K3
Guide to Pharmacology 9744
CONTENTS